ARCHIVES

ORI Says COMS Study Coordinator Committed Scientific Misconduct

This article is from The Cancer Letter archive.

Vol. 22 No. 15 | April 12, 1996

Download PDF Visit The Full Archive

Related Articles

Caution Advised for Hormone Replacement Therapy

March 21, 1986

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Major Changes Being Considered By NCI For FCRA

April 14, 1978

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975